Tuesday, 13 May 2025    HomeAbout UsContact Us    








You are here:
Inhibition of LPS Binding to MD-2 Co-Receptor for Suppressing TLR4-Mediated Expression of Inflammatory Cytokine by 1-Dehydro-10-Gingerdione From Dietary Ginger
Posted by Admin, Senior Editor in Ginger
Authored by PubMed
Topics: Ginger

  Mail To Friend    Printer Friendly Bookmark and Share

Ginger is an herb. The rhizome (underground stem) is used as a spice and also as a medicine. It can be used fresh, dried and powdered, or as a juice or oil. Ginger is commonly used to treat various types of "stomach problems," including motion sickness, morning sickness, colic, upset stomach, gas, diarrhea, nausea and vomiting after surgery, as well as loss of appetite. Other uses include treating upper respiratory tract infections, cough, and bronchitis.

Park SH, Kyeong MS, Hwang Y, Ryu SY, Han SB, Kim Y. Inhibition of LPS binding to MD-2 co-receptor for suppressing TLR4-mediated expression of inflammatory cytokine by 1-dehydro-10-gingerdione from dietary ginger. 1. Biochem Biophys Res Commun. 2012 Mar 23;419(4):735-40. Epub 2012 Feb 24.
Myeloid differentiation protein 2 (MD-2) is a co-receptor of toll-like receptor 4 (TLR4) for innate immunity. Here, we delineated a new mechanism of 1-dehydro-10-gingerdione (1D10G), one of pungent isolates from ginger (Zingiber officinale), in the suppression of lipopolysaccharide (LPS)-induced gene expression of inflammatory cytokines. 1D10G inhibited LPS binding to MD-2 with higher affinity than gingerol and shogaol from dietary ginger. Moreover, 1D10G down-regulated TLR4-mediated expression of nuclear factor-?B (NF-?B) or activating protein 1 (AP1)-target genes such as tumor necrosis factor ? (TNF-?) and interleukin-1?, as well as those of interferon (IFN) regulatory factor 3 (IRF3)-target IFN-? gene and IFN-? inducible protein 10 (IP-10) in LPS-activated macrophages. Taken together, MD-2 is a molecular target in the anti-inflammatory action of 1D10G.


Link to this article:   Show: HTML LinkFull LinkShort Link
Share or Bookmark this page: You will need to have an account with the selected service in order to post links or bookmark this page.

                 
  
Subscribe via RSS or email:
Follow us through RSS or email. Click the RSS icon to subscribe to our feed.

     
  

Related Articles:
Add a Comment
You must be registered and logged in to comment.





Topics
Research
Technology
News
Articles

Latest Articles
Understanding the Different Types of Colloidal Silver
Antibacterial Activity of Silver Nanoparticles Against Gram-Positive and Gram-Negative Bacteria
Antitumor Activity of Colloidal Silver on MCF-7 Human Breast Cancer Cells
Studies on Interaction of Colloidal Silver Nanoparticles WIth Five Different Bacterial Species
Some Effects of Weak Direct Current and Silver Ions on Experimental Osteomyelitis
Silver Anode Treatment of Chronic Osteomyelitis
Effects of Electrically Generated Silver Ions on Human Cells and Wound Healing
Copper-Silver Ionization for Legionella Control in Hospitals
Agion Technology: Antimicrobial Products for Food and Services Industries
Electrically Generated Silver Ions: Quantitative Effects on Bacterial and Mammalian Cells

Pages
No pages found.

Most Popular
Silver Anode Treatment of Chronic Osteomyelitis
Antibacterial Activity of Silver Nanoparticles Against Gram-Positive and Gram-Negative Bacteria
Understanding the Different Types of Colloidal Silver
Copper-Silver Ionization for Legionella Control in Hospitals
Electrically Generated Silver Ions: Quantitative Effects on Bacterial and Mammalian Cells
Antitumor Activity of Colloidal Silver on MCF-7 Human Breast Cancer Cells
Agion Technology: Antimicrobial Products for Food and Services Industries
Effects of Electrically Generated Silver Ions on Human Cells and Wound Healing
Studies on Interaction of Colloidal Silver Nanoparticles WIth Five Different Bacterial Species
Some Effects of Weak Direct Current and Silver Ions on Experimental Osteomyelitis

Archives (View more)
2011 • July


Copyright © 2025 . All rights reserved. RSSTagsPrivacyLegal and Terms of UseSitemap